VERTEX PHARMACEUTICALS INC (VRTX)
US92532F1003 - Common Stock
ChartMill assigns a Buy % Consensus number of 77% to VRTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 476.77. This target is 19.88% above the current price.
VRTX was analyzed by 38 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about VRTX.
In the previous month the buy percentage consensus was at a similar level.
VRTX was analyzed by 38 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-18 | Guggenheim | Maintains | Buy -> Buy |
| 2024-04-17 | UBS | Maintains | Buy -> Buy |
| 2024-04-15 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-04-12 | Canaccord Genuity | Maintains | Sell -> Sell |
| 2024-04-11 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2024-04-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-02-15 | Wolfe Research | Initiate | Outperform |
| 2024-02-06 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-02-06 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-02-06 | Barclays | Maintains | Overweight -> Overweight |
| 2024-02-06 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-02-06 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2024-02-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-02-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-02 | Bernstein | Downgrade | Outperform -> Market Perform |
| 2024-02-01 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-01-31 | Truist Securities | Maintains | Buy -> Buy |
| 2024-01-31 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-01-31 | Maxim Group | Downgrade | Buy -> Hold |
| 2024-01-24 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-01-24 | Canaccord Genuity | Downgrade | Hold -> Sell |
| 2024-01-12 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-01-09 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-12-14 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-12-14 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-12-11 | Barclays | Maintains | Overweight -> Overweight |
| 2023-12-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-05 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-11-22 | Stifel | Reiterate | Hold -> Hold |